HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chronic inflammation in a long-term cohort of HIV-infected patients according to the normalization of the CD4:CD8 ratio.

Abstract
In HIV-infected patients a low CD4:CD8 ratio can persist despite CD4 recovery with long-term antiretroviral treatment (ART). As CD4:CD8 inversion is considered a marker of immune-senescence, we aimed to assess if it was associated with the chronic inflammation state in aging patients with HIV. A total of 112 patients with a >15 year history of HIV infection and ART were included, 85 of whom were suppressed. All subjects were tested for interleukin (IL)-6, high-sensitivity (hs)-PCR, and D-dimer levels. Complete clinical, therapeutic, and hematochemical data were retrieved. Coreceptor tropism based on HIV-DNA gp120 genotyping was also available within the past 6 months. A progressive increase in the CD4:CD8 ratio over time was observed without reaching a plateau. Based on the CD4:CD8 ratio at the time of testing, patients were classified into group A (normal ratio ≥0.9) and group B (<0.9). A normal ratio was observed in 37% of patients. Variables associated with an inverted CD4:CD8 ratio were older age, nadir CD4, and detectable HIV viremia. No association between HIV subtype, coreceptor tropism, cytomegalovirus (CMV), hepatitis B virus (HBV), and hepatitis C virus (HCV) coinfections and CD4:CD8 ratio was observed. Group B patients showed a trend for a higher frequency of diabetes and hypertriglyceridemia compared to group A patients, but they did not differ in IL-6, hs-PCR, and D-dimer levels or in frequency of severe non-AIDS-associated events. In conclusion, CD4:CD8 ratio normalization occurs rarely, even after several years of ART. Chronic inflammation in patients aging with HIV does not seem to be directly dependent on the CD4:CD8 ratio. However, the persistent immune dysregulation expressed by a CD4:CD8 inversion might be linked to a higher risk of non-AIDS events, especially metabolic disorders.
AuthorsAnnalisa Saracino, Giuseppe Bruno, Luigia Scudeller, Anna Volpe, Pierluigi Caricato, Nicoletta Ladisa, Laura Monno, Gioacchino Angarano
JournalAIDS research and human retroviruses (AIDS Res Hum Retroviruses) Vol. 30 Issue 12 Pg. 1178-84 (Dec 2014) ISSN: 1931-8405 [Electronic] United States
PMID25360575 (Publication Type: Journal Article)
Chemical References
  • Anti-HIV Agents
  • Fibrin Fibrinogen Degradation Products
  • Interleukin-6
  • fibrin fragment D
Topics
  • Age Factors
  • Anti-HIV Agents (therapeutic use)
  • CD4-CD8 Ratio (statistics & numerical data)
  • Chronic Disease
  • Female
  • Fibrin Fibrinogen Degradation Products (analysis)
  • HIV Infections (complications, drug therapy, immunology)
  • Humans
  • Inflammation (etiology, immunology)
  • Interleukin-6 (blood)
  • Male
  • Middle Aged
  • Retrospective Studies
  • Viral Load (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: